 | • レポートコード：MRC2012A4099 • 出版社/出版日：GlobalInfoResearch / 2020年12月21日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、101ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：医療、製薬 |
| Single User | ￥515,040 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥772,560 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,030,080 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 本調査レポートでは、胃食道逆流症治療薬及びデバイスの世界市場を広く調査・分析し、今後の市場展望をまとめております。胃食道逆流症治療薬及びデバイスの種類別市場規模（治療薬、デバイス）、用途別市場規模（薬物治療、手術治療、低侵襲治療）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、メーカー別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・市場概要 ・メーカー情報（販売量、市場シェア、製品概要、SWOT分析）：Endogastric Solutions、Carbon Medical technologies、Medigus、Medtronic、Johnson & Johnson、 ・地域別グローバル市場分析 2015年-2020年 ・胃食道逆流症治療薬及びデバイスの北米市場（アメリカ、カナダ、メキシコ） ・胃食道逆流症治療薬及びデバイスのヨーロッパ市場（ドイツ、イギリス、フランス、ロシア、イタリア） ・胃食道逆流症治療薬及びデバイスのアジア市場（中国、日本、韓国、インド、東南アジア、オーストラリア） ・胃食道逆流症治療薬及びデバイスの南米市場（ブラジル、アルゼンチン） ・胃食道逆流症治療薬及びデバイスの中東・アフリカ市場（サウジアラビア、トルコ、エジプト、南アフリカ） ・種類別分析：治療薬、デバイス ・用途別分析：薬物治療、手術治療、低侵襲治療 ・地域別市場規模予測 2021年-2025年 ・販売チャネル、流通業者、代理店 ・調査の結果・結論 |
Market Overview
The global Gastro Esophageal Reflux Disease Drug and Devices market size is expected to gain market growth in the forecast period of 2020 to 2025, with a CAGR of xx% in the forecast period of 2020 to 2025 and will expected to reach USD xx million by 2025, from USD xx million in 2019.
The Gastro Esophageal Reflux Disease Drug and Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
Market segmentation
Gastro Esophageal Reflux Disease Drug and Devices market is split by Type and by Application. For the period 2015-2025, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
By Type, Gastro Esophageal Reflux Disease Drug and Devices market has been segmented into
Drugs
Devices
By Application, Gastro Esophageal Reflux Disease Drug and Devices has been segmented into:
Drugs Treatment
Surgical Treatment
Minimally Invasive Treatment
Regions and Countries Level Analysis
Regional analysis is another highly comprehensive part of the research and analysis study of the global Gastro Esophageal Reflux Disease Drug and Devices market presented in the report. This section sheds light on the sales growth of different regional and country-level Gastro Esophageal Reflux Disease Drug and Devices markets. For the historical and forecast period 2015 to 2025, it provides detailed and accurate country-wise volume analysis and region-wise market size analysis of the global Gastro Esophageal Reflux Disease Drug and Devices market.
The report offers in-depth assessment of the growth and other aspects of the Gastro Esophageal Reflux Disease Drug and Devices market in important countries (regions), including:
North America (United States, Canada and Mexico)
Europe (Germany, France, UK, Russia and Italy)
Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
South America (Brazil, Argentina, etc.)
Middle East & Africa (Saudi Arabia, Egypt, Nigeria and South Africa)
Competitive Landscape and Gastro Esophageal Reflux Disease Drug and Devices Market Share Analysis
Gastro Esophageal Reflux Disease Drug and Devices competitive landscape provides details by vendors, including company overview, company total revenue (financials), market potential, global presence, Gastro Esophageal Reflux Disease Drug and Devices sales and revenue generated, market share, price, production sites and facilities, SWOT analysis, product launch. For the period 2015-2020, this study provides the Gastro Esophageal Reflux Disease Drug and Devices sales, revenue and market share for each player covered in this report.
The major players covered in Gastro Esophageal Reflux Disease Drug and Devices are:
Endogastric Solutions
Carbon Medical technologies
Medigus
Medtronic
Johnson & Johnson
Among other players domestic and global, Gastro Esophageal Reflux Disease Drug and Devices market share data is available for global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately. Global Info Research analysts understand competitive strengths and provide competitive analysis for each competitor separately.
The content of the study subjects, includes a total of 15 chapters:
Chapter 1, to describe Gastro Esophageal Reflux Disease Drug and Devices product scope, market overview, market opportunities, market driving force and market risks.
Chapter 2, to profile the top manufacturers of Gastro Esophageal Reflux Disease Drug and Devices, with price, sales, revenue and global market share of Gastro Esophageal Reflux Disease Drug and Devices in 2018 and 2019.
Chapter 3, the Gastro Esophageal Reflux Disease Drug and Devices competitive situation, sales, revenue and global market share of top manufacturers are analyzed emphatically by landscape contrast.
Chapter 4, the Gastro Esophageal Reflux Disease Drug and Devices breakdown data are shown at the regional level, to show the sales, revenue and growth by regions, from 2015 to 2020.
Chapter 5, 6, 7, 8 and 9, to break the sales data at the country level, with sales, revenue and market share for key countries in the world, from 2015 to 2020.
Chapter 10 and 11, to segment the sales by type and application, with sales market share and growth rate by type, application, from 2015 to 2020.
Chapter 12, Gastro Esophageal Reflux Disease Drug and Devices market forecast, by regions, type and application, with sales and revenue, from 2020 to 2025.
Chapter 13, 14 and 15, to describe Gastro Esophageal Reflux Disease Drug and Devices sales channel, distributors, customers, research findings and conclusion, appendix and data source.
Table of Contents
1 Market Overview
1.1 Gastro Esophageal Reflux Disease Drug and Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Type: 2015 VS 2019 VS 2025
1.2.2 Drugs
1.2.3 Devices
1.3 Market Analysis by Application
1.3.1 Overview: Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Application: 2015 VS 2019 VS 2025
1.3.2 Drugs Treatment
1.3.3 Surgical Treatment
1.3.4 Minimally Invasive Treatment
1.4 Overview of Global Gastro Esophageal Reflux Disease Drug and Devices Market
1.4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Market Status and Outlook (2015-2025)
1.4.2 North America (United States, Canada and Mexico)
1.4.3 Europe (Germany, France, United Kingdom, Russia and Italy)
1.4.4 Asia-Pacific (China, Japan, Korea, India and Southeast Asia)
1.4.5 South America, Middle East & Africa
1.5 Market Dynamics
1.5.1 Market Opportunities
1.5.2 Market Risk
1.5.3 Market Driving Force
2 Manufacturers Profiles
2.1 Endogastric Solutions
2.1.1 Endogastric Solutions Details
2.1.2 Endogastric Solutions Major Business and Total Revenue (Financial Highlights) Analysis
2.1.3 Endogastric Solutions SWOT Analysis
2.1.4 Endogastric Solutions Product and Services
2.1.5 Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.2 Carbon Medical technologies
2.2.1 Carbon Medical technologies Details
2.2.2 Carbon Medical technologies Major Business and Total Revenue (Financial Highlights) Analysis
2.2.3 Carbon Medical technologies SWOT Analysis
2.2.4 Carbon Medical technologies Product and Services
2.2.5 Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.3 Medigus
2.3.1 Medigus Details
2.3.2 Medigus Major Business and Total Revenue (Financial Highlights) Analysis
2.3.3 Medigus SWOT Analysis
2.3.4 Medigus Product and Services
2.3.5 Medigus Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.4 Medtronic
2.4.1 Medtronic Details
2.4.2 Medtronic Major Business and Total Revenue (Financial Highlights) Analysis
2.4.3 Medtronic SWOT Analysis
2.4.4 Medtronic Product and Services
2.4.5 Medtronic Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
2.5 Johnson & Johnson
2.5.1 Johnson & Johnson Details
2.5.2 Johnson & Johnson Major Business and Total Revenue (Financial Highlights) Analysis
2.5.3 Johnson & Johnson SWOT Analysis
2.5.4 Johnson & Johnson Product and Services
2.5.5 Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
3 Sales, Revenue and Market Share by Manufacturer
3.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales and Market Share by Manufacturer (2018-2019)
3.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue and Market Share by Manufacturer (2018-2019)
3.3 Market Concentration Rate
3.3.1 Top 3 Gastro Esophageal Reflux Disease Drug and Devices Manufacturer Market Share in 2019
3.3.2 Top 6 Gastro Esophageal Reflux Disease Drug and Devices Manufacturer Market Share in 2019
3.4 Market Competition Trend
4 Global Market Analysis by Regions
4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Market Share by Regions
4.1.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales and Market Share by Regions (2015-2020)
4.1.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue and Market Share by Regions (2015-2020)
4.2 North America Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
4.3 Europe Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
4.4 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
4.5 South America Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
4.6 Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
5 North America by Country
5.1 North America Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Market Share by Country
5.1.1 North America Gastro Esophageal Reflux Disease Drug and Devices Sales and Market Share by Country (2015-2020)
5.1.2 North America Gastro Esophageal Reflux Disease Drug and Devices Revenue and Market Share by Country (2015-2020)
5.2 United States Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
5.3 Canada Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
5.4 Mexico Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
6 Europe by Country
6.1 Europe Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Market Share by Country
6.1.1 Europe Gastro Esophageal Reflux Disease Drug and Devices Sales and Market Share by Country (2015-2020)
6.1.2 Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue and Market Share by Country (2015-2020)
6.2 Germany Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
6.3 UK Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
6.4 France Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
6.5 Russia Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
6.6 Italy Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
7 Asia-Pacific by Regions
7.1 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Market Share by Regions
7.1.1 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales and Market Share by Regions (2015-2020)
7.1.2 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue and Market Share by Regions (2015-2020)
7.2 China Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
7.3 Japan Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
7.4 Korea Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
7.5 India Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
7.6 Southeast Asia Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
7.7 Australia Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
8 South America by Country
8.1 South America Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Market Share by Country
8.1.1 South America Gastro Esophageal Reflux Disease Drug and Devices Sales and Market Share by Country (2015-2020)
8.1.2 South America Gastro Esophageal Reflux Disease Drug and Devices Revenue and Market Share by Country (2015-2020)
8.2 Brazil Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
8.3 Argentina Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
9 Middle East & Africa by Countries
9.1 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Market Share by Country
9.1.1 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales and Market Share by Country (2015-2020)
9.1.2 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue and Market Share by Country (2015-2020)
9.2 Saudi Arabia Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
9.3 Turkey Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
9.4 Egypt Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
9.5 South Africa Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
10 Market Segment by Type
10.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales and Market Share by Type (2015-2020)
10.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue and Market Share by Type (2015-2020)
10.3 Global Gastro Esophageal Reflux Disease Drug and Devices Price by Type (2015-2020)
11 Global Gastro Esophageal Reflux Disease Drug and Devices Market Segment by Application
11.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Application (2015-2020)
11.2 Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Application (2015-2020)
11.3 Global Gastro Esophageal Reflux Disease Drug and Devices Price by Application (2015-2020)
12 Market Forecast
12.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales, Revenue and Growth Rate (2021-2025)
12.2 Gastro Esophageal Reflux Disease Drug and Devices Market Forecast by Regions (2021-2025)
12.2.1 North America Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (2021-2025)
12.2.2 Europe Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (2021-2025)
12.2.3 Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (2021-2025)
12.2.4 South America Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (2021-2025)
12.2.5 Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (2021-2025)
12.3 Gastro Esophageal Reflux Disease Drug and Devices Market Forecast by Type (2021-2025)
12.3.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales Forecast by Type (2021-2025)
12.3.2 Global Gastro Esophageal Reflux Disease Drug and Devices Market Share Forecast by Type (2021-2025)
12.4 Gastro Esophageal Reflux Disease Drug and Devices Market Forecast by Application (2021-2025)
12.4.1 Global Gastro Esophageal Reflux Disease Drug and Devices Sales Forecast by Application (2021-2025)
12.4.2 Global Gastro Esophageal Reflux Disease Drug and Devices Market Share Forecast by Application (2021-2025)
13 Sales Channel, Distributors, Traders and Dealers
13.1 Sales Channel
13.1.1 Direct Marketing
13.1.2 Indirect Marketing
13.2 Distributors, Traders and Dealers
14 Research Findings and Conclusion
15 Appendix
15.1 Methodology
15.2 Data Source
15.3 Disclaimer
15.4 About US
Table 1. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue (USD Million) by Type: 2015 VS 2019 VS 2025
Table 2. Breakdown of Gastro Esophageal Reflux Disease Drug and Devices by Company Type (Tier 1, Tier 2 and Tier 3)
Table 3. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue (USD Million) by Application: 2015 VS 2019 VS 2025
Table 4. Market Opportunities in Next Few Years
Table 5. Market Risks Analysis
Table 6. Market Drivers
Table 7. Endogastric Solutions Basic Information, Manufacturing Base and Competitors
Table 8. Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Major Business
Table 9. Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Total Revenue (USD Million) (2017-2018)
Table 10. Endogastric Solutions SWOT Analysis
Table 11. Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Product and Services
Table 12. Endogastric Solutions Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 13. Carbon Medical technologies Basic Information, Manufacturing Base and Competitors
Table 14. Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Major Business
Table 15. Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Total Revenue (USD Million) (2017-2018)
Table 16. Carbon Medical technologies SWOT Analysis
Table 17. Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Product and Services
Table 18. Carbon Medical technologies Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 19. Medigus Basic Information, Manufacturing Base and Competitors
Table 20. Medigus Gastro Esophageal Reflux Disease Drug and Devices Major Business
Table 21. Medigus Gastro Esophageal Reflux Disease Drug and Devices Total Revenue (USD Million) (2017-2018)
Table 22. Medigus SWOT Analysis
Table 23. Medigus Gastro Esophageal Reflux Disease Drug and Devices Product and Services
Table 24. Medigus Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 25. Medtronic Basic Information, Manufacturing Base and Competitors
Table 26. Medtronic Gastro Esophageal Reflux Disease Drug and Devices Major Business
Table 27. Medtronic Gastro Esophageal Reflux Disease Drug and Devices Total Revenue (USD Million) (2017-2018)
Table 28. Medtronic SWOT Analysis
Table 29. Medtronic Gastro Esophageal Reflux Disease Drug and Devices Product and Services
Table 30. Medtronic Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 31. Johnson & Johnson Basic Information, Manufacturing Base and Competitors
Table 32. Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Major Business
Table 33. Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Total Revenue (USD Million) (2017-2018)
Table 34. Johnson & Johnson SWOT Analysis
Table 35. Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Product and Services
Table 36. Johnson & Johnson Gastro Esophageal Reflux Disease Drug and Devices Sales, Price, Revenue, Gross Margin and Market Share (2018-2019)
Table 37. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Manufacturer (2018-2019) (K Units)
Table 38. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Manufacturer (2018-2019) (USD Million)
Table 39. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Regions (2015-2020) (K Units)
Table 40. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Regions (2015-2020)
Table 41. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Regions (2015-2020) (USD Million)
Table 42. North America Gastro Esophageal Reflux Disease Drug and Devices Sales by Countries (2015-2020) (K Units)
Table 43. North America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Countries (2015-2020)
Table 44. North America Gastro Esophageal Reflux Disease Drug and Devices Revenue by Countries (2015-2020) (USD Million)
Table 45. North America Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2015-2020)
Table 46. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales by Countries (2015-2020) (K Units)
Table 47. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Countries (2015-2020)
Table 48. Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue by Countries (2015-2020) (USD Million)
Table 49. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales by Regions (2015-2020) (K Units)
Table 50. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Regions (2015-2020)
Table 51. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue by Regions (2015-2020) (USD Million)
Table 52. South America Gastro Esophageal Reflux Disease Drug and Devices Sales by Countries (2015-2020) (K Units)
Table 53. South America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Countries (2015-2020)
Table 54. South America Gastro Esophageal Reflux Disease Drug and Devices Revenue by Countries (2015-2020) (USD Million)
Table 55. South America Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2015-2020)
Table 56. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales by Countries (2015-2020) (K Units)
Table 57. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Countries (2015-2020)
Table 58. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue by Countries (2015-2020) (USD Million)
Table 59. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2015-2020)
Table 60. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Type (2015-2020) (K Units)
Table 61. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Share by Type (2015-2020)
Table 62. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue by Type (2015-2020) (USD Million)
Table 63. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Share by Type (2015-2020)
Table 64. Global Gastro Esophageal Reflux Disease Drug and Devices Sales by Application (2015-2020) (K Units)
Table 65. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Share by Application (2015-2020)
Table 66. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Forecast by Regions (2021-2025) (K Units)
Table 67. Global Gastro Esophageal Reflux Disease Drug and Devices Market Share Forecast by Regions (2021-2025)
Table 68. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Forecast by Type (2021-2025) (K Units)
Table 69. Global Gastro Esophageal Reflux Disease Drug and Devices Market Share Forecast by Type (2021-2025)
Table 70. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Forecast by Application (2021-2025)
Table 71. Global Gastro Esophageal Reflux Disease Drug and Devices Market Share Forecast by Application (2021-2025)
Table 72. Direct Channel Pros & Cons
Table 73. Indirect Channel Pros & Cons
Table 74. Distributors/Traders/ Dealers List
List of Figures
Figure 1. Gastro Esophageal Reflux Disease Drug and Devices Picture
Figure 2. Global Sales Market Share of Gastro Esophageal Reflux Disease Drug and Devices by Type in 2019
Figure 3. Drugs Picture
Figure 4. Devices Picture
Figure 5. Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Application in 2018
Figure 6. Drugs Treatment Picture
Figure 7. Surgical Treatment Picture
Figure 8. Minimally Invasive Treatment Picture
Figure 9. Global Gastro Esophageal Reflux Disease Drug and Devices Market Status and Outlook (2015-2025) (USD Million)
Figure 10. United States Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 11. Canada Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 12. Mexico Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 13. Germany Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 14. France Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 15. UK Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 16. Russia Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 17. Italy Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 18. China Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 19. Japan Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 20. Korea Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 21. India Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 22. Southeast Asia Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 23. Australia Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025) (USD Million)
Figure 24. Brazil Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 25. Egypt Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 26. Saudi Arabia Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 27. South Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 28. Turkey Gastro Esophageal Reflux Disease Drug and Devices Revenue (Value) and Growth Rate (2015-2025)
Figure 29. Global Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Manufacturer in 2019
Figure 30. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Manufacturer in 2019
Figure 31. Top 3 Gastro Esophageal Reflux Disease Drug and Devices Manufacturer (Revenue) Market Share in 2019
Figure 32. Top 6 Gastro Esophageal Reflux Disease Drug and Devices Manufacturer (Revenue) Market Share in 2019
Figure 33. Key Manufacturer Market Share Trend
Figure 34. Global Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 35. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 36. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Regions (2015-2020)
Figure 37. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Regions in 2018
Figure 38. North America Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
Figure 39. Europe Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
Figure 40. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
Figure 41. South America Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
Figure 42. Middle East & Africa Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020)
Figure 43. North America Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 44. North America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Countries (2015-2020)
Figure 45. North America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Countries in 2018
Figure 46. North America Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2015-2020) (USD Million)
Figure 47. North America Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries in 2018
Figure 48. United States Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 49. Canada Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 50. Mexico Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 51. Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 52. Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2015-2020)
Figure 53. Europe Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries in 2019
Figure 54. Germany Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 55. UK Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 56. France Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 57. Russia Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 58. Italy Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 59. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 60. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Regions 2019
Figure 61. Asia-Pacific Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Regions 2019
Figure 62. China Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 63. Japan Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 64. Korea Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 65. India Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 66. Southeast Asia Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 67. South America Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 68. South America Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Countries in 2019
Figure 69. South America Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries in 2019
Figure 70. Brazil Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 71. Argentina Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 72. Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2015-2020) (USD Million)
Figure 73. Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Sales Market Share by Countries in 2019
Figure 74. Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries (2015-2020)
Figure 75. Middle East and Africa Gastro Esophageal Reflux Disease Drug and Devices Revenue Market Share by Countries in 2019
Figure 76. Saudi Arabia Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 77. Egypt Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 78. Turkey Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 79. South Africa Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2015-2020) (K Units)
Figure 80. Global Gastro Esophageal Reflux Disease Drug and Devices Sales and Growth Rate (2021-2025) (K Units)
Figure 81. Global Gastro Esophageal Reflux Disease Drug and Devices Revenue and Growth Rate (2021-2025) (USD Million)
Figure 82. North America Sales Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (2021-2025) (K Units)
Figure 83. Europe Sales Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (2021-2025) (K Units)
Figure 84. Asia-Pacific Sales Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (2021-2025) (K Units)
Figure 85. South America Sales Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (2021-2025) (K Units)
Figure 86. Middle East & Africa Sales Gastro Esophageal Reflux Disease Drug and Devices Market Forecast (2021-2025) (K Units)
Figure 87. Sales Channel: Direct Channel vs Indirect Channel
胃食道逆流症（GERD）治療薬の世界市場（～2026年） Gastroesophageal reflux disease (GERD), also known as acid reflux, is a long-term condition where stomach contents come back up into the esophagus resulting in either symptoms or complications. Patent expiry of blockbuster drugs prescribed for the treatment of acid reflux disorders is majorly attrib…- 逆流性腎症治療の世界市場（～2026年） Reflux nephropathy is kidney damage (nephropathy) due to urine flowing backward (reflux) from the bladder toward the kidneys. The symptoms of reflux nephropathy are comparable to nephrotic syndrome and infection of the urinary tract, though some individuals may not exhibit any evidence (symptom) of …
- ドライアイ治療薬・装置治療の世界市場（～2026年） Dry eye disease is a condition that affects the tear film and ocular surface. It is medically known as keratoconjunctivitis sicca. It is an ocular disorder caused by the lack of tear fluid to lubricate the eyes. There are primarily two types of dry eye conditions. One is aqueous tear-deficient dry e…
- 感染症治療の世界市場（～2026年） Treatment for Infectious Diseases. Treatment of viral infections such as HIV involves patient care and moral support including antiretroviral therapy. Bacterial infections can be treated by administering antibiotics to the patients. Market Analysis and Insights: Global Infectious Disease Treatment M…
- クッシング病治療の世界市場（～2026年） Cushing disease is caused by tumour in the pituitary gland which leads to excessive secretion of a hormone called adrenocorticotrophic (ACTH), which in turn leads to increasing levels of cortisol in the body. Cortisol is a steroid hormone released by the adrenal glands and helps the body to deal wit…